Organogenesis Announces Publication of Randomized Clinical Trial Results Demonstrating the Safety and Efficacy of NuShield for Diabetic Foot Ulcers

2 weeks ago

CANTON, Mass., Oct. 01, 2024 ( GLOBE NEWSWIRE ) -- Organogenesis Holdings Inc. ( Nasdaq: ORGO ) , a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, ...

Ticker	Sentiment	Impact
ORGO	Somewhat Bullish	21 %